Literature DB >> 2510722

Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.

M E Gold1, P A Bush, L J Ignarro.   

Abstract

This study examined the influence of lowered arterial levels of L-arginine on endothelium-dependent relaxation of isolated rings of bovine pulmonary artery. Incubation of arterial rings under tension for 24 hr in oxygenated Krebs bicarbonate solution at 37 degrees C resulted in the development of marked or complete tolerance to A23187 (calcium ionophore)- and acetylcholine-elicited relaxation. Relaxant responses to nitric oxide were unaffected. Addition of L-arginine did not relax control rings but did elicit marked endothelium-dependent relaxation of tolerant rings that was inhibited by oxyhemoglobin or methylene blue. L-Arginine also restored acetylcholine-elicited relaxation. Inclusion of L-canavanine in the 24 hr incubations protected against the development of tolerance. The tissue concentration of arginine was 3-fold lower in tolerant than control arterial rings and L-canavanine restored arterial arginine levels to control values. Therefore, depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510722     DOI: 10.1016/0006-291x(89)91518-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine.

Authors:  M Hecker; W C Sessa; H J Harris; E E Anggård; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.

Authors:  H Moritoki; H Ueda; T Yamamoto; T Hisayama; S Takeuchi
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

3.  Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin.

Authors:  G Abou-Mohamed; W H Kaesemeyer; R B Caldwell; R W Caldwell
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.

Authors:  D Beasley; J H Schwartz; B M Brenner
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Oral L-arginine supplementation has no effect on cardiovascular responses to lower body negative pressure in man.

Authors:  J M Hind; A C Doodson
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435

6.  Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells.

Authors:  R G Bogle; A R Baydoun; J D Pearson; G E Mann
Journal:  J Physiol       Date:  1996-01-01       Impact factor: 5.182

7.  Attenuation of contractions to acetylcholine in canine bronchi by an endogenous nitric oxide-like substance.

Authors:  Y Gao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance.

Authors:  S V Baudouin; P Bath; J F Martin; R Du Bois; T W Evans
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

9.  Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries.

Authors:  D Dou; X Zheng; X Qin; H Qi; L Liu; J U Raj; Y Gao
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

10.  Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.

Authors:  T Hayashi; J M Fukuto; L J Ignarro; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.